Aquilo Capital is a Hedge Fund in California with $503.74 mm assets under management, with a minimum investment of $1.00 mm. It has 116 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$503.74 mm
Address
Aquilo Capital
ONE LETTERMAN DRIVE, SUITE D4900
BUILDING D, THE PRESIDIO
SAN FRANCISCO
CA 94129
ONE LETTERMAN DRIVE, SUITE D4900
BUILDING D, THE PRESIDIO
SAN FRANCISCO
CA 94129
Phone
(415) 635-0141
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Aquilo Capital Management, LLC | $737.21 mm | |
Aquilo Capital Lo, L.P. | $220.28 mm | Hedge Fund |
Aquilo Capital Lo Offshore, LTD. | ||
Aquilo Capital Special Opportunity, L.P. | $13.20 mm | Hedge Fund |
Aquilo Capital, L.P. | $503.74 mm | Hedge Fund |
Aquilo Capital Offshore, LTD. |
Latest filings (excl ownership)
D/A
Indefinite amount in investment fund / Limited Partner Interests, sold $256.98 mm, 118 investors
29 Nov 23
D/A
Indefinite amount in investment fund / Limited Partner Interests, sold $256.23 mm, 118 investors
29 Nov 22
D/A
Indefinite amount in investment fund / Limited Partner Interests, sold $247.45M, 117 investors
29 Nov 21
D/A
Indefinite amount in investment fund / Limited Partner Interests, sold $230.89M, 113 investors
27 Nov 20
D/A
Indefinite amount in investment fund / Limited Partner Interests, sold $119.09M, 109 investors
29 Nov 19
D/A
Indefinite amount in investment fund / Limited Partner Interests, sold $104.03M, 92 investors
29 Nov 18
D/A
Indefinite amount in investment fund / Limited Partner Interests, sold $87.5M, 78 investors
29 Nov 17
D/A
Indefinite amount in investment fund / Limited Partner Interests, sold $71.92M, 76 investors
28 Nov 16
D/A
Indefinite amount in investment fund / Limited Partner Interests, sold $35.62M, 33 investors
8 Apr 14
D
Indefinite amount in investment fund / Limited partner interests
10 May 10
Latest ownership filings
4
Spero Therapeutics, Inc.
26 Sep 22
4
Spero Therapeutics, Inc.
28 Apr 22
4
Spero Therapeutics, Inc.
31 Mar 22
4
Spero Therapeutics, Inc.
16 Mar 22
4
Spero Therapeutics, Inc.
2 Mar 22
4
Spero Therapeutics, Inc.
23 Feb 22
4
Spero Therapeutics, Inc.
1 Feb 22
4
Spero Therapeutics, Inc.
26 Jan 22
4
Spero Therapeutics, Inc.
20 Jan 22
4
Spero Therapeutics, Inc.
12 Jan 22